Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03735238 · ClinicalTrials.gov registry record
Implementing the Decision-Aid for Lupus (IDEAL Strategy)
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 1,895
- Enrollment target
NCT03735238: Completed study, sponsored by University of Alabama at Birmingham.
NCT03735238 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 1,895 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03735238 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 1,895 participants
- Enrollment target
Study Summary
The study will attempt to put into practice a shared decision making (SDM) strategy, using an individualized, computerized decision- aid (DA) for Systemic lupus erythematosus (SLE).
Primary Outcome
Reach/penetration was measured by calculating a ratio of patients who were enrolled in the implementation project (# of patients who viewed the SLE PtDA) divided by the number of Eligible Participants at Each Clinical Site identified using the electronic medical record (EMR) in the respective clinic (# of eligible patients). The number of eligible patients was based on the average number of patients with a diagnosis of lupus seen in each clinic over the study period (2019-2023).
Interventions
- OTHER SMILE Computerized Decision-Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,895 participants |
| Start Date | 2018-12-15 |
| Est. Completion | 2025-06-10 |
What the finished NCT03735238 record still lists
NCT03735238 is an observational study that tracks outcomes without assigning an intervention. Its 1,895 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which SMILE Computerized Decision-Aid is the first listed.
NCT03735238 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03735238 about?
NCT03735238 is a clinical study titled "Implementing the Decision-Aid for Lupus (IDEAL Strategy)". The study will attempt to put into practice a shared decision making (SDM) strategy, using an individualized, computerized decision- aid (DA) for Systemic lupus erythematosus (SLE).
What is the current status of trial NCT03735238?
This trial is currently completed. The enrollment target is 1,895 participants. The study started on 2018-12-15. Estimated completion is 2025-06-10.
What interventions are being tested in trial NCT03735238?
The interventions under investigation include: SMILE Computerized Decision-Aid (OTHER).
Who is sponsoring clinical trial NCT03735238?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07308717 · 1,896 participants · Phase 4
Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol
- NCT03729180 · 1,900 participants · NA
The ImPreSS Trial: Pharmacogenomic Decision Making at Time of Surgery
- NCT05712200 · 1,900 participants · Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- NCT06929806 · 1,900 participants · Phase 3
Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI